Forepont Capital Partners

What is Forepont Capital Partners?

Forepont Capital Partners is a venture capital firm that specializes in healthcare investments, focusing predominantly on the biotech and medtech sectors, including digital health, devices, and diagnostics, both in Europe and the United States. Established in 2017 and headquartered in New York, Forepont has carved a niche in the neurology space, but their interests are not limited to this area.

They typically engage with startups at the seed, pre-Series A, and Series A stages, with investment amounts ranging from $2,000,000 to $15,000,000, with a sweet spot around $5,000,000.

They leverage their deep understanding of the science and an extensive network that includes medical experts and large pharmaceutical companies to provide hands-on support to entrepreneurs.

Forepont is highly selective in their investment approach, avoiding ventures outside healthcare, late-stage companies, or those based in emerging countries. Forepont Capital Partners prides itself on being more than just an investment firm; it's also actively involved in financing cutting-edge medical research, particularly in nerve cell re-myelination (CNS). This research has been a cornerstone of their recognition in the healthcare field since their partners began this journey in 2011.

Their established healthcare partners offer direct access to new investment opportunities, and they meticulously consider medical, human, financial, and ethical aspects before investing. Their strategic approach involves investing in start-ups before they reach an inflection point, providing an opportunity for Forepont’s experience to drive significant value creation.

Additionally, their comprehensive knowledge of American and European regulations helps support portfolio companies. Forepont’s mission encapsulates investing in startups poised to disrupt healthcare and delivering scientific, financial, and operational support to enhance performance and catalyze innovation in pursuit of new treatments that could transform the lives of patients globally.

What they say:

Founded in 2017 in New York, Forepont Capital Partners is a global asset manager in healthcare and life science.We developed strong and tight partnerships with industry leaders: physicians, researchers, key opinion leaders, academia, hospitals and large pharmaceutical groups.

What we look for: We invest in start-ups whose science will change the lives of numbers of patients. Forepont philanthropy funds basic and academic research that discovers new science. Our program for medical research is the heart of Forepont. Our funds investment performance is the engine. We continuously deploy resources and expertise around our passion for basic medical research and the performance of our start-ups to participate in the discovery of treatments that will change lives of millions.

How we help: StrategyInvesting in Bio&Med Tech before the inflection point allows Forepont’s experience, expertise and know-how to have an immediate and unique impact. Our team helps shape the startup to maximise the value creation.SupportOur deep knowledge of American and European regulations, structures and markets allows us to provide an important support at local and international levels.